Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study aims to uncover hidden delays in anal cancer diagnosis

NCT ID NCT07455942

Knowledge-focused Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 02, 2026 · Updated 2 times

Summary

This study looks at the care paths of 300 people with anal cancer to find out what causes delays in diagnosis. Researchers will track the time from first symptoms to diagnosis and check how screening and access to care affect outcomes. The goal is to improve awareness and help catch the disease earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients diagnosed with squamous cell carcinoma of the anal canal

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female ≥ 18 years 2. Histologically proven invasive or microinvasive squamous cell carcinoma of the anus 3. Having read and understood the information letter provided, either: i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy) 4. Affiliated with a social security system Exclusion Criteria: 1. Refusal to participate in the protocol 2. Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc. 3. Time since treatment initiation greater than 6 months 4. Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-induced cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anal canal squamous cell carcinoma human papillomavirus-related squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV-induced cancer Squamous cell carcinoma of the anal canal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    32 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • APHP Hôpital Tenon

    RECRUITING

    Paris, 75020, France

  • APHP_Hôpital Bichat Claude-Bernard

    RECRUITING

    Paris, 75018, France

  • APHP_Hôpital Cochin-Port Royal

    RECRUITING

    Paris, 75014, France

  • CH Annecy Genevois

    RECRUITING

    Épagny, 74370, France

  • CH Avignon

    NOT_YET_RECRUITING

    Avignon, 84000, France

  • CH Béthune

    RECRUITING

    Beuvry, 62660, France

  • CH Lens

    RECRUITING

    Lens, 62300, France

  • CH Vendée

    RECRUITING

    La Roche-sur-Yon, 85925, France

  • CH du Haut Anjou

    RECRUITING

    Château-Gontier, 53200, France

  • CHI Poissy-St Germain

    RECRUITING

    Poissy, 78300, France

  • CHRU Ponchaillou de Rennes

    RECRUITING

    Rennes, 35033, France

  • CHU Angers

    RECRUITING

    Angers, 49933, France

  • CHU Hôpital Nord - Marseille

    RECRUITING

    Marseille, 13006, France

  • CHU Montpellier

    RECRUITING

    Montpellier, 34090, France

  • CHU Orléans

    RECRUITING

    Orléans, 45000, France

  • Cabinet de proctologie

    RECRUITING

    Le Bouscat, 33110, France

  • Centre Hospitalier Intercommunal de Créteil

    RECRUITING

    Créteil, 94000, France

  • Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges

    RECRUITING

    Villeneuve-Saint-Georges, 94190, France

  • Clinique Belharra

    RECRUITING

    Bayonne, 64100, France

  • Clinique Saint-Grégoire

    RECRUITING

    Saint-Grégoire, 35760, France

  • Clinique du Palais

    RECRUITING

    Grasse, 06130, France

  • Groupe Hospitalier Diaconesses Croix Saint-Simon

    RECRUITING

    Paris, 75020, France

  • Hia Begin

    RECRUITING

    Saint-Mandé, 94160, France

  • Hôpital Bagatelle

    RECRUITING

    Talence, 33400, France

  • Hôpital Paris Saclay, GHNE

    RECRUITING

    Orsay, 91400, France

  • Hôpital Saint Joseph

    RECRUITING

    Paris, 75014, France

  • Hôpital St Joseph St Luc

    RECRUITING

    Lyon, 69007, France

  • Institut Mutualiste de Montsouris

    RECRUITING

    Paris, 75014, France

  • Institut régional du Cancer de Montpellier (ICM)

    RECRUITING

    Montpellier, 34298, France

  • Maison des consultations

    RECRUITING

    Quint-Fonsegrives, 31130, France

  • Polyclinique Pau Pyrénées

    RECRUITING

    Pau, 64000, France

  • Polyclinique du Parc Vivalto

    RECRUITING

    Cholet, 49300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.